Extracellular ATP drives pancreatic cancer cell invasion via purinergic receptor-integrin interactions
E. Tomas Bort, M. Joseph, Q. Wang, E. Carter, N. Roth, J. Gibson, A. Samadi, H. Kocher, S. Simoncelli, P. J. McCormick, R. P. Grose
This study identifies P2RY2 as a key purinergic receptor involved in pancreatic cancer invasion through interactions with integrins, suggesting therapeutic targeting potential.
bioRxiv · Oct 24, 2022Cancer Biology